Washington State Department of Health
(DOH)

At the first work group meeting, members introduced themselves and heard agency leaders’ intentions to gather input on the effectiveness of 2022 cannabis testing changes.

Leaders touched on several bills concerning cannabinoid regulation and “inactive” producer licenses in addition to a favorable court ruling and social equity program updates.

A public hearing on cannabinoid legislation had a mix of support from public officials and prevention groups, as well as opposition/other remarks from hemp and cannabis interests.

Representatives heard the WSLCB THC bill, a technical corrections bill was readied for the opposite house, and a senate floor session and rules meeting were scheduled for Wednesday.

A bill adding restrictions on manufacturing and sales of hemp cannabinoid products was generally well received, but many speakers disagreed with the allowable THC limits.

Senators heard supportive testimony on a bill addressing retail theft and four new bills were prepared for introduction, including two targeting concentrated cannabis products.

Unanimously supportive testimony on a bill to remove the cannabis excise tax for medical patients registered with the state called attention to problems around taxing medicine.

Republican representatives were poised to introduce a bill to radically revise the excise tax structure by THC concentration after the public weighed in against taxing patients.

Board members expressed their willingness to support multiple bills for medical cannabis patients and spoke at length about their approach to interacting with the state legislature.

The out-of-state ownership bill was heard, two seasoned bills were set for introduction, and medical cannabis patients would make their case for excise tax exemption in 2023.